Summary: A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.
Publications199 found, 100 shown here
- Laboratory diagnosis and characteristics of breakthrough varicella in childrenSheila Weinmann
Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon 97227, USA
J Infect Dis 197:S132-8. 2008..The value of highly elevated IgG titers needs further evaluation. Larger studies are needed to confirm these results...
- Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research NetworkJ A Taylor
Department of Pediatrics, University of Washington School of Medicine, Seattle 98103 8652, USA
Arch Pediatr Adolesc Med 154:302-6. 2000..To evaluate parental health beliefs regarding the varicella vaccine and to identify potential areas for interventions designed to increase immunization against varicella...
- The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccinationHester de Melker
Centre for Infectious Disease Epidemiology, National Institute of Public Health and the Environment, P O Box 1, 3720 BA Bilthoven, The Netherlands
Vaccine 24:3946-52. 2006..Insight into epidemiology of varicella zoster is needed for the assessment of the desirability of introduction of routine varicella zoster vaccination...
- The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibodyJay M Lieberman
Miller Children s Hospital, UCLA Center for Vaccine Research, Long Beach, CA 90806, USA
Pediatr Infect Dis J 25:615-22. 2006..An additional objective was to evaluate the persistence of antibodies 1 year postvaccination...
- The burden of varicella complications before the introduction of routine varicella vaccination in GermanyJohannes G Liese
Dr von Hauner Children s Hospital, Ludwig Maximilians University, Munich, Germany
Pediatr Infect Dis J 27:119-24. 2008..The true burden of varicella complications in Germany is not known. We investigated the incidence and pattern of varicella complications in children and adolescents using 3 independent surveillance sources...
- Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider educationK R Ehresmann
Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis 55414, USA
Am J Public Health 90:1917-20. 2000..This study sought to determine physicians' attitudes and practices regarding varicella vaccine...
- Aging, immunity, and the varicella-zoster virusAnn Arvin
Stanford University School of Medicine, Stanford, Calif, USA
N Engl J Med 352:2266-7. 2005
- Varicella vaccines and measles, mumps, rubella, and varicella vaccineLucia Ferro Bricks
Departamento de Pediatria, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, SP, Brazil
J Pediatr (Rio J) 82:S101-8. 2006..To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella...
- The effect of vaccination on the epidemiology of varicella zoster virusW J Edmunds
Immunisation Division, Colindale, London NW9 5EQ, UK
J Infect 44:211-9. 2002..Meanwhile sensitive surveillance of both chickenpox and shingles is essential in countries that have implemented, or are about to implement, varicella vaccination...
- Instituting a routine varicella vaccination program in Canada: an economic evaluationDenis Getsios
Caro Research, Montreal, Canada
Pediatr Infect Dis J 21:542-7. 2002..The evaluation of a program of vaccination of 12-month-old children, with and without a catch-up program for susceptible 12-year-olds, is presented here...
- Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virusYasuyuki Gomi
Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan
J Virol 76:11447-59. 2002..Furthermore, the Oka vaccine virus was completely distinguishable from P-Oka and 54 clinical isolates by seven restriction-enzyme fragment length polymorphisms that detected differences in the DNA sequence...
- An elementary school outbreak of varicella attributed to vaccine failure: policy implicationsBrian R Lee
Immunization, Tuberculosis, and International Health Section, Infectious Disease Epidemiology, Prevention, and Control Division, Minnesota Department of Health, Minneapolis 55414, USA
J Infect Dis 190:477-83. 2004....
- Hospitalizations for varicella in the United States, 1988 to 1999Karin Galil
Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 21:931-5. 2002..Varicella epidemiology is changing with increasing use of the varicella vaccine...
- Complications of varicella requiring hospitalisation before and after the introduction of varicella vaccine in a children's hospital in TaiwanYu Yu Chuang
Division of Paediatric Infectious Diseases, Chang Gung Children s Hospital, 5 Fu Shin Street, Kweishan, Taoyuan, Taiwan
Eur J Pediatr 162:112-3. 2003
- Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccinationChristian R Frey
Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA, and Faculty of Biosciences, University of Witten Herdecke, Witten, Germany
J Infect Dis 188:40-52. 2003..Varicella vaccination of 3 VZV-immune subjects was associated with increases in IE62 peptide-specific CD8(+) T cells, a finding indicating that in vivo re-exposure boosts memory immunity to this important viral protein...
- Prevention strategies: experience of varicella vaccination programmesDavid Patrick
University of British Columbia, Centre for Disease Control, Vancouver, BC, Canada
Herpes 14:48-51. 2007..Ongoing surveillance for the reactivation of herpes zoster and safety programmes are also highlighted as key recommendations...
- The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policyIe Bin Lian
Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua 50058, Taiwan
Vaccine 29:1448-54. 2011..The current study provides important implications for the current vaccination policy...
- Complete DNA sequences of two oka strain varicella-zoster virus genomesSueli L Tillieux
Viral Vaccines Research and Development, GlaxoSmithKline Biologicals, Rue de l Institut, 89 P31 005, B 1330 Rixensart, Belgium
J Virol 82:11023-44. 2008....
- Varicella: epidemiological aspects and vaccination coverage in the Veneto RegionVincenzo Baldo
Department of Environmental Medicine and Public Health, Institute of Hygiene, University of Padua, Padua, Italy
BMC Infect Dis 9:150. 2009..To evaluate parameters at the start of the programme, we conducted a study to describe the epidemiology of varicella infection and coverage rates for varicella vaccine in the Veneto Region (North-East Italy)...
- Varicella outbreaks after vaccine licensure: should they make you chicken?U Buchholz
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 104:561-3. 1999..Vaccine effectiveness was within the range predicted by the literature. Vaccination led to a lower attack rate in the highly vaccinated CCC and appeared to protect from severe disease...
- Growth, morbidity and mortality after chickenpox infection in young children in Guinea-BissauAnja Poulsen
Projecto de Saude de Bandim, Guinea Bissau, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark
J Infect 51:307-13. 2005..To examine whether chickenpox in children below 2 years of age is associated with post-infection changes in growth, morbidity or mortality...
- Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)Nicolas Goulleret
Sanofi Pasteur MSD, Lyon, France
Vaccine 28:5878-82. 2010..The European VZVIP provides data on VZV clade distribution...
- An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006Philip L Gould
Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 28:678-81. 2009..In October 2006, the Arkansas Department of Health was notified of a varicella outbreak among students where some received a second dose during an outbreak-related vaccination campaign in February 2006...
- Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in TaiwanHung Fu Tseng
Institute of Medical Research, Chang Jung Christian University, 396, Sec l, Chang Jung Rd, Kway Jen, Tainan 711, Taiwan, ROC
Vaccine 24:5341-8. 2006..The reductions also occurred in every age group including infants and adults. This study showed significant evidence of vaccine impact with a marked decline in clinical cases in the short term...
- Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccineL Zerboni
Department of Pediatrics, Stanford University School of Medicine, California 94305 5208, USA
J Infect Dis 177:1701-4. 1998..In summary, varicella immunization induced long-term humoral and cellular immunity, and initial differences between cell-mediated responses in children and adults diminished over time...
- Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised casesPaolo Bonanni
Department of Public Health, University of Florence, Viale Morgagni 48, 50134 Florence, Italy
Vaccine 26:5619-26. 2008..Overall, our analysis confirmed the favourable clinical and economic impact of routine varicella vaccination with two doses of vaccine in Italy...
- Varicella vaccination in AustraliaK K Macartney
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, The Children s Hospital at Westmead, New South Wales, Australia
J Paediatr Child Health 41:544-52. 2005..The potential impact of varicella vaccination on the incidence of herpes zoster is also discussed...
- Molecular analysis of the Oka vaccine strain of varicella-zoster virusKoichi Yamanishi
National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan
J Infect Dis 197:S45-8. 2008....
- Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005Yung Hsiu Lin
Division of Infectious Diseases, Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
J Microbiol Immunol Infect 42:5-12. 2009..This study investigated the epidemiological characteristics and disease burden of varicella during the introduction of the varicella vaccine for mass vaccination in Taiwan...
- Postlicensure safety surveillance for varicella vaccineR P Wise
Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, FDA CBER HFM 225, Rockville, MD 20852 1448, USA
JAMA 284:1271-9. 2000....
- Varicella vaccination in Europe - taking the practical approachPaolo Bonanni
Department of Public Health, University of Florence, Florence, Italy
BMC Med 7:26. 2009....
- VaricellaUlrich Heininger
Division of Paediatric Infectious Diseases and Vaccinology, University Children s Hospital, Basel, Switzerland
Lancet 368:1365-76. 2006..Similar immunisation programmes have been adopted by some other countries, including Uruguay, Germany, Taiwan, Canada, and Australia, and are expected to be implemented more widely in future...
- Impact of varicella vaccination on health care utilizationFangjun Zhou
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 294:797-802. 2005..However, national surveillance data are incomplete, and comprehensive data regarding outpatient as well as hospital utilization have not been reported...
- Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)Mona Marin
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 56:1-40. 2007..ACIP also approved criteria for evidence of immunity to varicella...
- Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccineTimo Vesikari
University of Tampere Medical School, Tampere, Finland
Pediatr Infect Dis J 26:632-8. 2007....
- A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and VarivaxKeith S Reisinger
Primary Physicians Research, Pittsburgh, PA 15241, USA
Pediatrics 117:265-72. 2006..A second dose of a varicella-containing vaccine may result in similar benefits...
- Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United StatesMatthew M Davis
Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan 48109 0456, USA
Pediatrics 114:786-92. 2004..Previous studies have not found such effects. We studied trends in varicella-related hospitalization rates and associated charges before and after introduction of varicella vaccine...
- Universal varicella vaccination in the Veneto Region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescentsV Baldo
Department of Environmental Medicine and Public Health, Institute of Hygiene, University of Padua, Italy
Euro Surveill 12:E071101.3. 2007
- Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric populationF Bonsignori
Department of Paediatrics, University of Florence, Anna Meyer Children s Hospital, Via Luca Giordano, 13, I 50132, Florence, Italy
Infection 35:444-50. 2007..A retrospective study was conducted to provide epidemiological data on hospitalization for complicated and uncomplicated chickenpox in a pediatric population...
- Is Europe ready to embrace a policy of universal varicella vaccination?J Ramet
Universiteit Antwerpen, UZA and Paola Kinderziekenhuis ZNA, Antwerp, Belgium
Int J Clin Pract 59:1326-33. 2005..A universal varicella vaccination policy is an option that needs to be considered for Europe not only in medical terms but also because it would be socially and economically appropriate...
- Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposureAlexandra Katsafadou
Second Pediatric Clinic, Agia Sophia Childrens Hospital, Goudi, Athens, Greece
Eur J Pediatr 168:23-5. 2009..In conclusion, based on our local epidemiologic data, presumptive varicella vaccination should be offered to all adolescents with the exception of the subgroup of adolescents with household exposure...
- [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis]M Knuf
Kinderklinik und Kinderpoliklinik, Johannes Gutenberg Universitat, Langenbeckstrasse 1, 55101 Mainz
Klin Padiatr 218:203-12. 2006..From these findings it can be concluded that universal varicella vaccination is a strategy which should be encouraged, from a medical, epidemiological, but also economic viewpoint...
- Decline in mortality due to varicella after implementation of varicella vaccination in the United StatesHuong Q Nguyen
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
N Engl J Med 352:450-8. 2005..Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella...
- Survey of the status of self-paid varicella vaccination among children one to six years of age in TaiwanSui Ling Liao
Department of Pediatrics, Chang Gung Children s Hospital and Chang Gung Memorial Hospital, Taoyuan, Taiwan
J Microbiol Immunol Infect 40:112-5. 2007..Prior to 2004, the mass immunization program in Taiwan did not include varicella vaccine; however, parents could have their children vaccinated by the self-payment option...
- Varicella vaccination of children in the United States: assessment after the first decade 1995-2005Charles Grose
Virology Laboratory, Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA 52242, USA
J Clin Virol 33:89-95; discussion 96-8. 2005..In addition, data from varicella vaccination programs in Europe should provide further insight into the effectiveness of varicella vaccination in different geographic and ethnic populations...
- Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002Aisha O Jumaan
Centers for Disease Control and Prevention, Atlanta, Georgia 30345, USA
J Infect Dis 191:2002-7. 2005..We assessed the impact that varicella vaccination has on the incidence of varicella and of HZ...
- Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy childrenMarkus Knuf
Childrens Hospital, Johannes Gutenberg University Hospital, Mainz, Germany
Pediatr Infect Dis J 25:12-8. 2006....
- Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 yearsTimo Vesikari
University of Tampere Medical School, Tampere, Finland
Pediatr Infect Dis J 26:153-8. 2007..Given the overlap in MMR and varicella vaccination schedules, development of a combined vaccine appears logical and would facilitate the introduction of 2 doses of varicella vaccination in healthy children with no additional injections...
- Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccineMatthew M Davis
Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI, USA
Pediatrics 119:258-64. 2007..We assessed physicians' attitudes about the 1-dose varicella vaccination program and whether physicians think a 2-dose recommendation is needed to reduce the risk of breakthrough disease...
- Varicella vaccination in Europe: are we ready for a universal childhood programme?Nitu Sengupta
Centre for Child Health, Royal London Hospital, 38 New Road, Whitechapel, London, E1 2AX, UK
Eur J Pediatr 167:47-55. 2008..The SIEVE recommends the implementation of such a policy as soon as financially and practically possible...
- A vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsM N Oxman
Shingles Prevention Study Mail code 111F 1, VA San Diego Healthcare System, 3350 La Jolla Village Dr, San Diego, CA 92161, USA
N Engl J Med 352:2271-84. 2005..We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults...
- Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003Mona Marin
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 115:900-5. 2005..We investigated this outbreak to examine reasons for its occurrence, including vaccine failure...
- Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)Barbara J Kuter
Merck Research Laboratories, P 0 Box 4, West Point 19426, Pennsylvania, USA
Hum Vaccin 2:205-14. 2006..Inc, West Point, PA) was evaluated in five clinical trials. Use of ProQuad would result in fewer injections for children and would facilitate universal immunization against all four diseases...
- Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introductionMaria Theodoridou
First Department of Paediatrics, Aghia Sophia Children s Hospital, Thivon and Levadias Str, 11527, Athens, Greece
Eur J Pediatr 165:273-4. 2006
- Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern TurkeyHandan Alp
Department of Pediatrics, Ataturk Universitesi, 25 240 Erzurum, Turkey
Health Policy 72:119-24. 2005..The results were presented in order to design a strategy for vaccination against varicella-zoster virus (VZV)...
- Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005Sandra S Chaves
Centers for Disease Control and Prevention, Atlanta, Georgia 30332, USA
J Infect Dis 197:S127-31. 2008..Continued surveillance of the risk and characteristics of breakthrough disease will be needed, to monitor the effect of the new 2-dose vaccine recommendation for children...
- Risk of herpes zoster in adults immunized with varicella vaccineSophie Hambleton
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA
J Infect Dis 197:S196-9. 2008..00 case/1000 person-years. Overall, the incidence of HZ in this cohort, therefore, is similar to published data for the US population in the prevaccine era...
- Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZVM Brisson
Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
J Med Virol 70:S31-7. 2003....
- Outbreak of varicella at a day-care center despite vaccinationKarin Galil
Centers for Disease Control and Prevention, Atlanta, USA
N Engl J Med 347:1909-15. 2002..We investigated an outbreak of varicella in a population of children with a high proportion of vaccinees who were attending a day-care center in a small community in New Hampshire...
- Epidemiology of Varicella-Zoster Virus in England and WalesM Brisson
Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5WQ, United Kingdom
J Med Virol 70:S9-14. 2003..3 days and 25 vs. 4 deaths per 100,000 case). These results provide base-line estimates should mass varicella vaccination be introduced in England and Wales...
- Changing varicella epidemiology in active surveillance sites--United States, 1995-2005Dalya Guris
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Infect Dis 197:S71-5. 2008..Continued surveillance will be important to monitor the impact that the 2-dose vaccine policy in children has on varicella epidemiology...
- Epidemiology of varicella in Connecticut, 2001-2005Lynn E Sosa
Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Infect Dis 197:S90-3. 2008..Continued surveillance is needed in order to monitor changing trends in varicella epidemiology...
- Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality dataH Rawson
Guy's King's College, St. Thomas's Hospital School of Medicine and Dentistry, London, UK
BMJ 323:1091-3. 2001..More of those who died were born outside United Kingdom than expected (12% v 4%). CONCLUSIONS: Chickenpox is not a mild disease. Deaths in adults are increasing, both in number and proportion...
- Varicella disease after introduction of varicella vaccine in the United States, 1995-2000Jane F Seward
Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop E 62, Atlanta, GA 30333, USA
JAMA 287:606-11. 2002..Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11,000 hospitalizations, and 100 deaths every year...
- Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in GermanyPeter Wutzler
Institute for Antiviral Chemotherapy, Friedrich Schiller University of Jena, Winzerlaer Strasse 10, Germany
Med Microbiol Immunol 191:89-96. 2002..In summary, routine childhood varicella vaccination appears to be a highly efficient strategy to significantly reduce the sizeable burden of varicella and would lead to net savings from both the societal but also the payer perspective...
- Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005J Quian
Pediatric Department, Republic University, Montevideo, Uruguay
Arch Dis Child 93:845-50. 2008..We assessed the impact of the Uruguayan varicella vaccination programme during 2005, 6 years after its introduction...
- Pediatric sentinel surveillance of vaccine-preventable diseases in ItalyMarta Luisa Ciofi degli Atti
Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanita, Rome, Italy
Pediatr Infect Dis J 21:763-8. 2002..In January, 2000, a pediatric sentinel network was launched, with the aim of monitoring in a timely and accurate way the geographic and temporal trends of vaccine-preventable diseases...
- Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy childrenHenry R Shinefield
Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
Pediatr Infect Dis J 21:555-61. 2002....
- Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpoxM Brisson
Immunisation Division, PHLS Communicable Disease Surveillance Centre, London, UK
Vaccine 20:2500-7. 2002..Mass varicella vaccination is expected to cause a major epidemic of herpes-zoster, affecting more than 50% of those aged 10-44 years at the introduction of vaccination...
- An outbreak of varicella despite vaccinationJorge W Quian
N Engl J Med 348:1405-7; author reply 1405-7. 2003
- Epidemiology of varicella zoster virus infection in Canada and the United KingdomM Brisson
PHLS CDSC, and City University, London
Epidemiol Infect 127:305-14. 2001..Finally, our results provide baseline estimates of varicella and zoster incidence and morbidity for VZV vaccine effectiveness and cost-effectiveness studies...
- Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European dataC Aebi
Department of Pediatrics, University of Bern, CH 3010 Inselspital, 3010, Bern, Switzerland
Vaccine 19:3097-103. 2001..The peak at 7-10 years may represent a transient loss of detectable antibody by some individuals...
- Empirical data on the varicella situation in Germany for vaccination decisionsS Wagenpfeil
Institute for Medical Statistics and Epidemiology, Technical University of Munich, Germany
Clin Microbiol Infect 10:425-30. 2004..In addition, significant economic benefits can be expected, mainly because of the high level of indirect health costs in Germany...
- Use of a computerized database to study the effectiveness of an attenuated varicella vaccineJusten H Passwell
Safra Children s Hospital, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
Pediatr Infect Dis J 23:221-6. 2004..The varicella vaccine Varilrix (GlaxoSmithKline) was introduced in Israel in June 2000 as an optional vaccination for children...
- An economic analysis of the universal varicella vaccination program in the United StatesFangjun Zhou
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia, USA
J Infect Dis 197:S156-64. 2008....
- Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004Andrea Streng
University Children s Hospital, Department of Paediatric Infectiology and Immunology, Julius Maximilians University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
Vaccine 28:5738-45. 2010..Additional programmes targeting paediatricians' and parents' acceptance of varicella vaccination are needed to achieve the WHO-defined goal of at least 85% coverage...
- Reactions of pediatricians to the recommendation for universal varicella vaccinationR D Newman
Department of Pediatrics, University of Washington School of Medicine, Children s Hospital and Medical Center, Seattle, USA
Arch Pediatr Adolesc Med 152:792-6. 1998....
- Varicella immunization practices and the factors that influence themS J Schaffer
Strong Children s Research Center, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, NY, USA
Arch Pediatr Adolesc Med 153:357-62. 1999..To evaluate the varicella immunization practices of physicians in Rochester, NY, and to identify factors that predict whether physicians administer varicella vaccine to children...
- Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmesL Salleras
General Directorate of Public Health, Department of Health and Social Security, Autonomous Government of Catalonia, Spain
Vaccine 19:183-8. 2000..These results suggest that the best vaccination strategy in Catalonia would be to add a temporary vaccination programme of pre-adolescents at 12 years to routine vaccination at 15 months...
- Varicella vaccination in Australia and New ZealandKristine K Macartney
National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead, Westmead, Australia
J Infect Dis 197:S191-5. 2008..The anticipated licensure of combination measles-mumps-rubella-varicella vaccines in both countries may lead to future schedule changes...
- The postmarketing safety profile of varicella vaccineR G Sharrar
Worldwide Product Safety and Epidemiology, Merck Research Laboratories, BLB 30, PO Box 4, West Point, PA 19486, USA
Vaccine 19:916-23. 2000..Eleven patients were hospitalized with complications of breakthrough varicella infection...
- The effectiveness of the varicella vaccine in clinical practiceM Vazquez
Department of Pediatrics, Yale University School of Medicine, New Haven, Conn 06520 8064, USA
N Engl J Med 344:955-60. 2001..A live attenuated varicella vaccine was approved for use in the United States in March 1995 and is recommended for all susceptible persons 12 months of age or older...
- A new combination vaccine for measles, mumps, rubella and varicellaGrazyna Zareba
Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642, USA
Drugs Today (Barc) 42:321-9. 2006..The ProQuad combination vaccine facilitates implementation of varicella vaccination into routine childhood immunization schedules and will help to protect children against these four potentially serious diseases...
- Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1Saro H Armenian
Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA
Pediatr Infect Dis J 25:368-70. 2006..The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination...
- [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention]S W Wassilew
Dermatologische Klinik, Klinikum Krefeld
MMW Fortschr Med . 2006
- An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patientsAmanda L Adler
Department of Pediatrics, University of Washington, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Infect Control Hosp Epidemiol 29:866-70. 2008..We describe an outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients in October 2004...
- Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccinesD I Cohen
Department of Epidemiology and Preventive Medicine, Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel
Infection 34:208-13. 2006..This large-scale study provides up-to-date estimates of Varicella zoster virus (VZV) age-specific seroprevalence and characteristics of VZV transmission in a representative sample of the Israeli population...
- Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of lifeVolker Schuster
Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
Pediatr Infect Dis J 27:724-30. 2008..This study (104389/NCT00127023) was undertaken to assess the immunogenicity and safety of a new refrigerator-stable tetravalent MMRV vaccine after 1 dose and after 2 doses administered during the second year of life...
- Varicella-zoster virus infectionsAnne A Gershon
Columbia University College of Physicians and Surgeons, New York, NY, USA
Pediatr Rev 29:5-10; quiz 11. 2008
- A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicellaJose Ramet
Department of Pediatrics, Universitair Ziekenhuis Antwerpen, Antwerp Belgium
Int J Infect Dis 11:S49-55. 2007..Varicella is often considered to be a benign disease of childhood. In fact, varicella is associated with serious complications and mortality even among healthy individuals...
- The safety profile of varicella vaccine: a 10-year reviewSusan A Galea
Merck Research Laboratories, Clinical Risk Management and Safety Surveillance, North Wales, Pennsylvania 19454 1099, USA
J Infect Dis 197:S165-9. 2008..Disseminated Oka VZV was identified in 6 immunocompromised patients and 1 patient with Down syndrome. This review has shown that the vaccine is generally safe and well tolerated...
- Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005Sandra S Chaves
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 197:S170-7. 2008..Ongoing safety surveillance and further studies may shed light on some of the hypothesized associations...
- Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zosterN Sengupta
Department of Virology, Centre for Infectious Diseases, Institute of Cell Molecular Sciences, Queen Mary School of Medicine and Dentistry, Barts, Whitechapel, London, E1 2AT, United Kingdom
J Infect Dis 196:1014-20. 2007..The data presented provide a baseline against which to evaluate changes in the molecular epidemiology of varicella-zoster virus and the effect of immunization with the Japanese Oka vaccine strain...
- Perspective on live varicella vaccineAnne A Gershon
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
J Infect Dis 197:S242-5. 2008....
- Development of varicella vaccineMichiaki Takahashi
Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
J Infect Dis 197:S41-4. 2008..3%] of 260 vs. 12 [17.1%] of 70, respectively). Because of the pathogenesis of VZV, the incidence of latency and of HZ is predicted to be lower among vaccine recipients than among individuals who have experienced varicella...
- Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in GermanyA Sauerbrei
Institute of Virology and Antiviral Therapy, Friedrich Schiller University of Jena, Jena, Germany
J Med Virol 79:1025-31. 2007..As reasons, the spread of viruses, which may be imported originally by persons immigrating from warmer climates, or the recombination between wild-and vaccine-type viruses have to be considered...
- Primary vaccine failure after 1 dose of varicella vaccine in healthy childrenDavid E Michalik
Division of Pediatric Infectious Diseases, Columbia University Medical Center, New York, New York 10032, USA
J Infect Dis 197:944-9. 2008..A second dose of varicella vaccine is expected to increase seroconversion rates and vaccine effectiveness...
- Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in TaiwanC K Chang
Department of Sport Management and Sport Science Research Center, National Taiwan College of Physical Education, 16, Sec 1, Shuan Shih Road, Taichung 404, Taiwan, ROC
Med Mal Infect 37:222-8. 2007..The aim of this study was to explore the geographical difference of VZV antibody seroprevalence among children in private vaccination areas in Taiwan, controlling for potential factors relating to varicella susceptibility...
- A combination vaccine against measles, mumps, rubella and varicellaMarkus Knuf
Pediatric University Hospital, Johannes Gutenberg University, Mainz, Germany
Drugs Today (Barc) 44:279-92. 2008..For other countries considering introducing these vaccines, the advantages for children, parents and healthcare providers of protecting against four diseases in a single vaccine should be noted...
- Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccineBarbara Watson
Immunization Program Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, Pennsylvania 19146, USA
J Infect Dis 197:S143-6. 2008....
- Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virusMark L Quinlivan
Skin Virus Laboratory, Institute of Cell and Molecular Medicine, London, United Kingdom
J Infect Dis 190:793-6. 2004..This finding suggests that, between the time of inoculation of the vaccine and development of rash, selection of single strains occurs. The results have general implications for the pathogenesis of varicella-zoster virus...
Research Grants102 found, 100 shown here
- VARICELLA ZOSTER VIRUSAnne Gershon; Fiscal Year: 2002..They will investigate gene expression during putative latency, including the comparative virulence of wild type and vaccine type VZV. ..
- BEHAVIORAL INTERVENTION FOR HERPES ZOSTER RISK IN AGINGMichael Irwin; Fiscal Year: 2003....
- Molecular Epidemiology of Fatal Prostate CancerSheila Weinmann; Fiscal Year: 2006..The case-control study design will provide maximum statistical power for analysis of these relationships, particularly in the important African-American subgroup. ..
- PEDIATRICS AIDS CLINICAL TRIALS GROUPAnne Gershon; Fiscal Year: 2006..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
- VZV Receptors and Infective MechanismsAnne Gershon; Fiscal Year: 2007..It may also make it possible to develop a safer and more efficacious vaccine. ..
- VARICELLA ZOSTER--RECEPTORS AND INFECTIVE MECHANISMSAnne Gershon; Fiscal Year: 2000....
- TRAINING IN PEDIATRIC INFECTIOUS DISEASEAnne Gershon; Fiscal Year: 2007..The renewal of this training grant will enable us to continue a training program that has so far been highly successful at this University during the past 5 years. ..
- Chronic Kidney Disease in Children Study (C-Kid)Susan Furth; Fiscal Year: 2007..g. rapid progressors) and appropriately matched controls (e.g. non-progressors); and cross-cohort analyses utilizing parallel cohorts. ..
- Patient Oriented Research in Pediatric Kidney DiseaseSusan Furth; Fiscal Year: 2007....
- Assessing Functional Outcomes in Adolescent with ESRDSusan Furth; Fiscal Year: 2002..This experience will give Dr. Furth the tools she needs to develop into an independent clinical investigator in a nurturing academic environment. ..
- ASSESSING PATIENT OUTCOMES IN PEDIATRIC ESRDSusan Furth; Fiscal Year: 2003..Furth the tools she needs to develop into an independent clinical investigator in a nurturing academic environment. ..
- Clinical Performance Measures & Outcomes in AdolescentsSusan Furth; Fiscal Year: 2005..abstract_text> ..
- Predictors of Cancer Screening in Diverse PracticesRichard Zimmerman; Fiscal Year: 2004..Without understanding the barriers to prevention from multiple vantage points, the rates of preventive services are unlikely to reach 2010 goals and needless cancer deaths will occur. ..
- VIRAL GASTROENTERITIS--BASIS OF PROTECTION AND VIRULENCEAnn Arvin; Fiscal Year: 2001..In order to better understand the molecular and virologic basis of virulence and/or host tropism, we will identify relevant steps in the viral replication cycle in vivo that are restricted on the basis of host range. ..
- Protective Mechanisms Against Pandemic Respiratory VirusAnn Arvin; Fiscal Year: 2007..These innovations will have broad relevance for for understanding human immunity against microbial pathogens of concern for biodefense. ..
- VARICELLA ZOSTER VIRUS--T CELL/SKIN TROPISMS AND IMMUNITAnn Arvin; Fiscal Year: 2003..These parallel investigations of VZV pathogenesis and immunity are directly linked by their practical relevance for improving live attenuated varicella vaccines. ..
- ONTOGENY OF MEASLES IMMUNITY IN INFANTSAnn Arvin; Fiscal Year: 2007..Understanding the maturation of host responses to viral antigens during the first year of life has general relevance for vaccine strategies in infancy. ..
- Varicella-zoster Virus Tegument Proteins in PathogenesisAnn Arvin; Fiscal Year: 2003..A better understanding of the genetic mechanisms that are required for VZV virulence in skin, T cells and neural cells will guide the design of 'second generation' live attenuated varicella vaccines. ..
- Varicella-zoster Virus: Tegument Proteins in PathogenesisAnn Arvin; Fiscal Year: 2009..abstract_text> ..
- IMMUNITY & VIRAL REPLICATION IN CHILDREN WITH VARICELLAAnn Arvin; Fiscal Year: 1993....
- Using MEPS Data to Inform Public-Plan ConsumerismMatthew Davis; Fiscal Year: 2007..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. ..
- ONTOGENY OF MEASLES IMMUNITY IN INFANTSAnn Arvin; Fiscal Year: 1999
- Sleep and Immune Mechanisms in Rheumatoid ArthritisMichael Irwin; Fiscal Year: 2009..Results from this study will guide the development of interventions that target disordered sleep with potential effects on disability in RA. ..
- Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune MechanismsMichael R Irwin; Fiscal Year: 2010..This project will constitute the first, randomized controlled clinical trial of the effects of TCC on sleep outcomes in breast cancer survivors, and will advance psychobiological models of insomnia treatment mechanisms. ..
- T regulatory Cells in HSV Immunity and ImmunopathologyBARRY ROUSE; Fiscal Year: 2007..Finally, a number of different strategies will be used to modulate the function of Treg cells in vivo to either increase immunity to HSV or reduce the damage resulting from HSV-induced immunopathology. ..
- ROCHESTER EPIDEMIOLOGY PROJECTSteven Jacobsen; Fiscal Year: 2004..Although the basic data system has worked well, these aims will allow the applicants to extend the capabilities of this research infrastructure and insure its future usefulness. ..
- Alcoholism: Sleep and Cytokines in African AmericansMichael Irwin; Fiscal Year: 2005..g., cytokine antagonists) for sleep disturbance in alcoholism. ..
- MECHANISMS IN HERPETIC STROMAL KERATITISBARRY ROUSE; Fiscal Year: 2002..This approach may provide an alternative and/or adjunct means of managing the clinical expression of HSK in the natural host. ..
- Epidemiology of human metapneumovirus(hMPV) infectionMarietta Vazquez; Fiscal Year: 2007..abstract_text> ..
- Aging: Cytokine Mechanisms and Treatment of InsomniaMichael Irwin; Fiscal Year: 2009..This study will advance psychobiological models of disordered sleep and the potential benefits of two readily exportable behavioral interventions for promoting improvements in sleep outcomes in the elderly. ..
- ROCHESTER EPIDEMIOLOGY PROJECTSteven Jacobsen; Fiscal Year: 2005..abstract_text> ..
- KERATITIS TREATMENT WITH DRUG-CONTAINING IMMUNOLIPOSOMESBARRY ROUSE; Fiscal Year: 1991..The results of our study may produce a vehicle for topical treatment of herpetic keratitis that is more effective than existing methods of treatment of stromal keratitis and may be effective when administered only once daily...
- OUTCOMES FOR IPV: PATIENT AND PROVIDER PERSPECTIVESMichael Rodriguez; Fiscal Year: 2003..abstract_text> ..
- ANTIGENIC DETERMINANTS OF VARICELLA VIRUSCharles Grose; Fiscal Year: 2006..These proposed VZV studies will provide further insight into the multiple functions of gE and the gE:gI complex. ..
- Mechanisms in Herpetic KeratitisBARRY ROUSE; Fiscal Year: 2006..Investigations also focus on angiogenesis during clinical HSK and the relevance of therapies designed to inhibit neovascularization. ..